Antithymocyte Globulin in the Treatment of D-Penicillamine—Induced Aplastic Anemia
A patient who received antithymocyte globulin therapy for aplastic anemia due to D-penicillamine therapy is described. Bone marrow recovery and peripheral blood recovery were complete 1 month and 3 months, respectively, after treatment, and blood transfusion or other therapies were not necessary in a follow-up period of more than 2 years. Use of antithymocyte globulin may be the optimal treatment of D-penicillamine—induced aplastic anemia.
Key wordsAntithymocyte globulin Aplastic anemia D-penicillamine
Unable to display preview. Download preview PDF.
- 5.Alvara-Gracia JM, Castaneda-Sanz S, Arranz R, Ariza A, Sabanco P, Ossorio C. Antithymocyte globulin in the treatment of gold induced severe aplastic anemia.J Rheumatol. 1988;15:43–45.Google Scholar
- 6.Yaffe IA. Penicillamine. In: McCarty DJ, ed.Arthritis and Allied Conditions. 10th ed. Philadelphia, Pa: Lea & Febiger; 1985: 502–511.Google Scholar